Genetic testing and antiplatelet treatment: Still way to go?

International Journal of Cardiology

Volumn 187, Issue 1, 2015, Pages 63-65

  Oikonomou, Evangelos ^a   Papageorgiou, Nikolaos ^a   Papaioannou, Spyridon ^a   Toutouzas, Konstantinos ^a   Latsios, George ^a   Siasos, Gerasimos ^a   Tousoulis, Dimitris ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Clopidogrel; CYP2C19; Platelet inhibition; Platelet resistance; Polymorphisms; Stent thrombosis

Indexed keywords

CLOPIDOGREL; PRASUGREL; TICAGRELOR; ANTITHROMBOCYTIC AGENT;

ACUTE CORONARY SYNDROME; ARTICLE; BIOTRANSFORMATION; DISEASE COURSE; DRUG ABSORPTION; DRUG ELUTING STENT; GENE FREQUENCY; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; PLATELET REACTIVITY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STENT THROMBOSIS; THROMBOCYTE FUNCTION; CORONARY THROMBOSIS; GENETICS; PROCEDURES;

CORONARY THROMBOSIS; DRUG-ELUTING STENTS; GENETIC TESTING; HUMANS; PLATELET AGGREGATION INHIBITORS;

EID: 84929163939     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.03.281     Document Type: Editorial

References (24)

1. F. Airoldi, A. Colombo, N.Morici, et al., Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment, Circulation 116 (2007) 745-754.
2. P.A. Gurbel, K.P. Bliden, K. Guyer, et al., Platelet reactivity in patients and recurrent events post-stenting: Results of the PREPARE POST-STENTING Study, J. Am. Coll. Cardiol. 46 (2005) 1820-1826.
3. P.A. Gurbel, K.P. Bliden, W. Samara, et al., Clopidogrel effect on platelet reactivity in patients with stent thrombosis: Results of the CREST Study, J. Am. Coll. Cardiol. 46 (2005) 1827-1832.
4. T. Geisler, H. Langer, M. Wydymus, et al., Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation, Eur. Heart J. 27 (2006) 2420-2425.
5. T. Geisler, C. Zurn, R. Simonenko, et al., Early but not late stent thrombosis is influenced by residual platelet aggregation in patients undergoing coronary interventions, Eur. Heart J. 31 (2010) 59-66.
6. M.J. Price, S. Endemann, R.R. Gollapudi, et al., Prognostic significance of postclopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation, Eur. Heart J. 29 (2008) 992-1000.
7. J. Park, D.H. Shin, B.K. Kim, et al., Relationship between aspirin/clopidogrel resistance and intra-stent thrombi assessed by follow-up optical coherence tomography after drug-eluting stent implantation, Eur. Heart J. Cardiovasc. Imaging 14 (2013) 1181-1186.
8. Z.J. Wang, Y.J. Zhou, Y.Y. Liu, et al., Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent, Thromb. Res. 124 (2009) 46-51.
9. L. Li, H.Y. Li, R. Qiao, et al., Predictive value of antiplatelet resistance on early stent thrombosis in patients with acute coronary syndrome, Chin. Med. J. 126 (2013) 626-633.
10. G.N. Levine, E.R. Bates, J.C. Blankenship, et al., 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions, Circulation 124 (2011) 2574-2609.
11. M. Valgimigli, Identifying responsiveness to oral P2Y12 receptor blockers: Platelet function assays and genetic tests, J. Cardiovasc. Med. (Hagerstown) 14 (Suppl. 1) (2013) S8-S15.
12. G. Scalone, I. Coviello, L. Barone, et al., Evidence of increased platelet reactivity in the first six months after acute ST segment elevation myocardial infarction, Thromb. Res. 128 (2011) 174-178.
13. D. Taubert, N. von Beckerath, G. Grimberg, et al., Impact of P-glycoprotein on clopidogrel absorption, Clin. Pharmacol. Ther. 80 (2006) 486-501.
14. J.L. Mega, S.L. Close, S.D. Wiviott, et al., Cytochrome P450 genetic polymorphisms and the response to prasugrel: Relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes, Circulation 119 (2009) 2553-2560.
15. D. Sibbing, W. Koch, D. Gebhard, et al., Cytochrome 2C1917 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement, Circulation 121 (2010) 512-518.
16. D. Tousoulis, G. Siasos, M. Zaromitidou, et al., The impact of CYP2C19 genotype on cardiovascular events and platelet reactivity in patientswith coronary artery disease receiving clopidogrel, Int. J. Cardiol. 168 (2013) 1594-1596.
17. D. Tousoulis, S. Kioufis, G. Siasos, et al., The impact of AMPD1 gene polymorphismon vascular function and inflammation in patients with coronary artery disease, Int. J. Cardiol. 172 (2014) e516-e518.
18. G. Pare, S.R. Mehta, S. Yusuf, et al., Effects of CYP2C19 genotype on outcomes of clopidogrel treatment, N. Engl. J. Med. 363 (2010) 1704-1714.
19. D. Tousoulis, G. Siasos,M. Zaromytidou, et al., The role of the cytochrome P450 polymorphisms in clopidogrel efficacy and clinical utility, Curr. Med. Chem. 18 (2011) 427-438.
20. T. Simon, C. Verstuyft, M. Mary-Krause, et al., Genetic determinants of response to clopidogrel and cardiovascular events, N. Engl. J. Med. 360 (2009) 363-375.
21. J.D. Roberts, G.A. Wells, M.R. Le May, et al., Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): A prospective, randomised, proof-of-concept trial, Lancet 379 (2012) 1705-1711.
22. G. Siasos, D. Tousoulis, C. Stefanadis, Mechanisms affecting platelet response to antiplatelet therapy in patients with ST-segment elevation myocardial infarction, J. Am. Coll. Cardiol. 62 (2013) 1636.
23. G. Campo, G. Parrinello, P. Ferraresi, et al., Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention relationship with gene polymorphisms and clinical outcome, J. Am. Coll. Cardiol. 57 (2011) 2474-2483.
24. J.P. Collet, T. Cuisset, G. Range, et al., Bedside monitoring to adjust antiplatelet therapy for coronary stenting, N. Engl. J. Med. 367 (2012) 2100-2109.